Immunologic Response to Kansui in Treated HIV+ Individuals: a Dose Escalation Study
Clinical trial NCT02531295 · TERMINATED
Trial details
- NCT number
- NCT02531295
- Sponsor
- University of California, San Francisco
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-15
- Primary completion
- 2020-03-19
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.